Analyst Insights - Digital Health Posts

Read our Analysts’ insights and expert opinions on the latest healthcare technology industry developments and market trends. Signify Research provides both free insights and premium insights which are only available to subscribers of "Signify Premium Insights".
Click on the premium insights link below to filter for just the premium content.



Signify Premium Insight: FDA Approval for Samsung NeuroLogica as Interest in Photon Counting CT Grows

Signify Premium Insights Subscription Required

31st March 2022 – Photon counting represents the next great technological leap for CT, unlocking new possibilities for the modality. As yet, only two vendors have had their systems cleared by the FDA, with a very different approach taken by each.

State of Diagnostic Imaging Procedure Volumes

In the years prior to the Covid-19 pandemic, the worldwide accessibility and usage of medical imaging has made marginal but marked gains. This is due to both the increased investment in healthcare and the advances in technology that improve image acquisiton speed and/or image quality. According to the Lancet in October 2021, 47% of the […]

VC Funding for Medical Imaging AI Companies Totals Almost $3.5 Billion Since 2015

31st March 2022 – Capital investment for medical imaging AI companies has reached almost $3.5 billion since 2015, and despite the Covid-19 pandemic, a record $814 million was raised in 2021. There has also been an emergence of the “$100m club” of those vendors that have raised more than $100 million in capital funding.

Signify Premium Insight: Headwinds Abound as AI Vendors Seek Seal of Approval

Signify Premium Insights Subscription Required

30th March 2022 – Signify Research has recently updated its AI regulatory database. While the medical imaging AI market has progressed, and the number of approved solutions continues to grow, several clouds have formed on the horizon.

US Ambulatory EHR Market Shake-up at HIMSS

30th March 2022 – During, and in the run up to, HIMSS there were several announcements from Epic, Meditech and Allscripts that have the potential to shake up the US ambulatory EHR market. Here’s our take.